In the present study, the effect of Hydroxy Propyl Methyl Cellulose (HPMC) on the crystallization of ortho-aminobenzoic acid (OABA) was investigated by seeded and unseeded cooling crystallization experiments. The influence of HPMC on the induction time, crystal shape of Forms I and II of OABA and the polymorphic transformation time was studied.
Introduction
Impurities in a crystallizer can have an incredibly large effect on the properties of the crystals produced in term of size distribution, shape and aspect ratio, polymorphic form and purity.
They can inhibit crystal growth and delay nucleation as well as induce the nucleation of a different polymorphic form. A common model to describe the rate of crystal growth in solution in the presence of impurities was proposed in the late nineties by Kubota and Mullin [1] [4] . The equations are based on the pinning mechanism of Cabrera and Vermilyea for the inhibition of step advancement considering one-dimensional adsorption of the impurities on the step lines. The model has been successfully used to quantitatively describe the growth rate of organic and inorganic compounds in the presence of impurities [4] [10] .
While growth kinetic in the presence of impurities is a relatively well-understood phenomenon [11] - [12] the effect on nucleation is still being studied [13] - [15] . Impurities can induce nucleation of a different polymorphic form [16] - [18] and have an effect on the time of polymorphic transformation [19] . The nucleation of the stable polymorph can be strongly inhibited by the presence of the impurity allowing the formation and growth of a metastable form [19] - [21] . Tailor-made and structurally related additives can promote nucleation of certain polymorphs because of structural similarities between them [22] [23] . Additives can be absorbed on surfaces (templates) and induce heterogeneous nucleation of the target polymorph without the risk of incorporation in the crystal structure [24] [29] . They can also delay nucleation [30] and promote the formation of very small crystals [31] , sometimes in an amorphous form [14] . More often, polymeric additives (HPMC, PEG, PVP, PAA etc.), most of which are commonly used as excipients, have been used to modify nucleation and growth rates of several drugs. The use of common excipients to control polymorphism, shape and size of crystals is particularly convenient as they do not need to be removed or washed away after filtration. Vetter et al. (2011) used the surfactant Pluronic F127 to slow down the growth of ibuprofen [32] . Similar studies were conducted by Alonzo et al. (2012) and Oucherif et al. (2013) who analysed and modelled the growth and nucleation kinetics of felopidine in the presence of HPMC [33] , [34] . The same research group also used HPMC to nucleate amorphous flutamide [14] and several other polymeric additives to inhibit growth of ritonavir [35] [36] [37] . In some cases polymers can promote growth: in particular, it was found that a very small amount of ethylene dinitrotetraacetic acid disodium salt (EDTA) could accelerate the growth of potassium dihydrogen phosphate (KDP) crystals by forming molecular complexes with adventitious impurities in solution and eliminating their inhibiting effect [38] . Recently, a mathematical description of the effect of one or more additive on the shape of KDP crystals was developed using population balance equations with the purpose of controlling the shape of the produced crystals [6] [7] .
This work constitutes a comprehensive study of the effect of the polymeric additive HPMC on the growth and nucleation mechanisms of two polymorphs of ortho-aminobenzoic acid. A combination of PAT tools and off-line solid state characterization techniques was used to understand the action of HPMC on the shape and size of the crystals of both Form I and II of the studied compound. The results of this study show how common excipients can be used to tailor morphology and polymorphism of organic compounds with significant impact on the manufacturing of pharmaceuticals in particular.
Materials and methods
Ortho-aminobenzoic acid (OABA) was purchased from Sigma-Aldrich (purity >98 %).
Isopropyl alcohol (IPA 99.97 % grade, Fisher Scientific), and ultrapure water obtained via a Millipore ultra-pure water system were used as solvents. OABA has three known different polymorphic forms: (i) Form I is the stable form at room temperature, (ii) Form II is the most metastable at low temperature and it is usually obtained by cooling crystallization; it is enantiotropically related to Form I (transition temperature around 60 °C) and monotropically related to the more stable Form III; (iii) Form III it is usually very difficult to nucleate during cooling crystallization from solution, and is normally produced by sublimation or by polymorphic transformation of Form I at high temperatures. Forms I and III are enantiotropically related with a transition temperature around 50 °C [39] - [41] The procedure used was identical to the one described in the previous section, samples were taken and analysed off-line.
Transformation experiments
The effect of several concentrations of HPMC on the kinetics of the polymorphic transformation from Form II to Form I of OABA was investigated with this set of experiments.
Four solutions of 10% IPA and 90% water w/w at OABA concentration of 0.0133 g/g solvent were prepared (saturation temperature around 40 °C). HPMC was added in different concentrations: 0, 3, 5 and 10 ppm. After the solution was prepared, the temperature was raised to 50 °C and kept for 30-40 min to allow a complete dissolution of the solid. After that, the temperature was decreased to 20 °C with a -0.5 °C/min cooling rate allowing nucleation of OABA Form II, and then kept constant at 20 °C until complete transformation to Form I.
Each transformation experiment was repeated at least twice using a new solution. The polymorphic transformation times were determined by tracking two specific Raman peaks corresponding to Forms I and II of OABA, respectively. Form I was associated to the 1038 cm -1 peak while Form II to the 770 cm -1 peak. The height to zero of the peaks was monitored during the experiment. After nucleation, 5 mL samples were taken during the polymorphic transformation and at the end of the experiment. The solids were analysed off-line to check the morphology and confirm the polymorphic composition.
Form I growth experiments
Isothermal seeded growth experiments were performed in water at additive concentrations of A population balance model (PBM) based parameter estimation approach was used to determine the kinetic parameters for the system. For a seeded experiment in a batch stirred reactor, neglecting secondary nucleation, agglomeration and breakage, the population balance equation (PBE) can be written as:
where is the average particle number density function, is time, is the particle characteristic length and is the growth rate which can be defined as:
where is the growth kinetic constant (function of the temperature), is the supersaturation level defined as the ratio between solute concentration and equilibrium concentration at the considered temperature, and is the order of the growth kinetics.
In this work the method of moments was used to solve the PBE. Moments can be defined as a function of in the following way:
Using the moments, equation (5) can be converted to a system of ordinary differential equations which can be easily solved. The first three moments (zeroth, first and second) were used for the parameter estimation:
The mass balance equation on OABA is written as:
where is the solute concentration, is the shape factor ( /6 for spherical particles) and is the density of the crystals.
The parameters and will be estimated iteratively for all performed experiments by minimizing the following objective function:
The function ode15s in Matlab R2013a was used to solve the system of equations (8)- (11) and a combination of fminsearch and fmincom optimization factions was used to estimate and by minimizing the objective function (12).
Results and discussion

Nucleation of Form I (water)
A lower nucleation temperature was recorded with increasing concentration of HPMC as shown in Figure 2 . The addition of 10 ppm of additive to the solvent generated a decrease in the nucleation temperature of more than 7 °C, which indicates that HPMC has an inhibitory effect on the nucleation of OABA Form I. It was also found that this additive can modify the shape of the crystals; therefore, it also inhibits growth of the stable polymorph. 
Nucleation of form II (90% water and 10% IPA w/w)
Similar nucleation experiments at several concentrations of HPMC were performed in 90 % water and 10 % IPA in order to study the effect of the additive on the kinetics of nucleation of the metastable Form II. Figure 5 shows the nucleation temperature of Form II at increasing concentration of HPMC. Dissimilarly to the case of Form I, nucleation of Form II does not seem to be affected by the presence of the additive; the nucleation temperatures do not change significantly with the addition of HPMC. However, the additive has clearly an effect on the growth of Form II crystals as shown in the SEM images in Figure 6 . Form II nucleated from 10 % IPA and 90 % water w/w usually has a flat needle shape (see Figure 6a) . With the addition of HPMC the edges of the crystals become more irregular with a similar effect that was noticed on Form I.
Polymorphic transformation kinetics of Form II OABA crystals into Form I
Although the nucleation temperature of Form II is not affected by the presence of HPMC in solution, a longer transformation time from Form II to I was observed. Table 1 
Growth kinetics OABA Form I (water)
A change in shape of the crystals of Form I in the presence of HPMC was observed in both water and 10% IPA and water, indicating that this additive has an effect on the growth kinetics of the stable polymorph. In order to quantitatively study this effect, further seeded isothermal experiments were conducted and a population balance model was used to estimate This trend is typical of size dependent growth systems that can't be described using the method of moments to solve the population balance equations [42] . However, as shown in Figure 10 , the simulated concentrations at different amounts of HPMC in solution follow reasonably well the experimental values, meaning that the model used, although very simple, is sufficient to represent the studied system, especially at high concentrations of additive.
The FBRM probe was used during the growth experiments to ensure the absence of secondary nucleation, breakage and/or agglomeration. Figure 11 shows the trend of the total counts during the seeded experiments: after an initial sudden increase due to seeding the vessel the number of counts remained stable, indicating that significant agglomeration and secondary nucleation or breakage were not occurring. 
Conclusions
In the present work a complete study on the effect of HPMC on nucleation and growth of two polymorphs of OABA was conducted. It was found that the additive inhibits nucleation of Form I but not for Form II. Additionally, because of the nucleation inhibition for the stable Form I, also the transformation time from Form II to Form I was found to be longer in the presence of HPMC.
Changes in shape for both Forms I and II were observed in the presence of the additive suggesting an inhibition of the growth rate for both polymorphs. It is worth noticing that the final shape of Form I strongly depended not only on the amount of HPMC in solution but also on the solvent used. Form I crystals grown from water presented a flat needle shape with edges that became more and more irregular as the amount of HPMC increased. Crystals of Form I grown from 10% IPA and water instead presented a flat prismatic shape in the absence of HPMC with increasing width as the additive was added to the solution.
Seeded isothermal desupersaturation experiments were also performed in water in order to quantitatively estimate the growth kinetics of Form I at different amount of HPMC. It was found that the additive exponentially inhibit growth of Form I in the chosen solvent in good accordance with experimental data.
This work shows the effectiveness of a polymeric additive in tailoring both the morphology and the polymorphism of an organic compound. Polymers can be used to modify shape and size of the crystals in order to improve the properties of the final drug as well as the downstream operations. The main advantages of this type of additives are their intrinsic safety (many are already used as excipients in pharmaceutical formulations) and the decreased likelihood of significant incorporation in the API crystal structure due to their large molecular size, thus having significant effect on morphology and polymorphism often without detectable effect on purity.
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